German study of a new memory questionnaire
Part of Brain & nervous system, Mental health clinical trials.
This study tests a new questionnaire designed to help doctors better understand early memory or thinking problems. It takes place at a memory clinic in Munich and is for people who are already coming in for dementia testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a scheduled appointment for dementia testing at the Alzheimer Therapie- und Forschungszentrum in Munich.
- You must be able to understand and sign a consent form (with help if needed).
- You must be able to read and write.
- You cannot have very advanced dementia that requires full-time nursing care.
- You must be able to make your own decisions about joining the study (with or without support).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people over time to better understand how memory and thinking complaints progress in early Alzheimer’s disease (from “subjective cognitive decline” to mild cognitive problems). It may help researchers understand who is likely to decline and how symptoms change, which could support future treatments.
This study follows people with mild cognitive impairment or dementia and their family caregivers over time. It aims to learn more about how these conditions progress and how to improve care, especially for those living in Bavaria.
This study looks at past memory test scores to see if they can predict how quickly memory declines in people with Alzheimer's disease. It aims to help doctors plan better care.
This study looks at how “slower movement” and brain changes relate to memory and thinking problems in people with early dementia (and some related conditions). It may help researchers understand what brain differences go with these symptoms, using tests and an MRI scan.
This trial studies people diagnosed with Alzheimer’s disease who are at a moderate stage of decline. It likely involves cognitive (memory/thinking) testing and care-partner input to help track changes over time.
This study creates a registry for people who are using newly approved Alzheimer's medications. It tracks how these treatments work over time and may help researchers learn more about diagnosing and treating Alzheimer's.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.